Your Unread Messages in Pharmacy
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Jill Baker
MDLinx Career Center
MGMA Data Breaks Down Physician Compensation
MDLinx Reminder
MDLinx
Did you see this newsletter?
Smartest Doc Challenge
MDLinx
Psychiatric Clinical Pearls for Pharmacists
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA & NSAID use on the rise
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
1 Recent developments in the treatment of heart failure: highlights from the American Heart Associations Scientific Sessions, Los Angeles, California, 3 7 December 2012 Expert Opinion on Investigational Drugs, June 20, 2013 Review Article
2 Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation Circulation: Arrhythmia and Electrophysiology, June 20, 2013 Clinical Article
3 The clinical significance of home blood pressure measurements for the prevention and management of high blood pressure Clinical and Experimental Pharmacology and Physiology, June 19, 2013 Clinical Article
4 Beta-blockers and pulmonary function in the general population: The Rotterdam Study British Journal of Clinical Pharmacology, June 19, 2013 Clinical Article
5 Do patients on statins also need niacin Full Text JAAPA, June 19, 2013 Clinical Article
6 Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation Circulation, June 18, 2013 Clinical Article
7
Heart rate reduction in heart failure: ivabradine or beta blockers
Heart Failure Reviews, June 18, 2013
Review Article
Clinical Article
Exclusive Author Commentary
8 Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study European Journal of Clinical Pharmacology, June 18, 2013 Clinical Article
9 Icosapent ethyl for the treatment of hypertriglyceridemia Expert Opinion on Pharmacotherapy, June 18, 2013 Review Article
10 The impact of smoking on clinical efficacy and pharmacodynamic effects of clopidogrel: a systematic review and meta-analysis Heart, June 18, 2013 Evidence Based Medicine Review Article Clinical Article
11 The efficiency of cardiovascular risk assessment: do the right patients get statin treatment Heart, June 18, 2013 Clinical Article
12 Clinical outcome in cardiac transplant recipients receiving tacrolimus retard Transplantation Proceedings, June 18, 2013 Clinical Article
13 New therapies to reduce low-density lipoprotein cholesterol Current Opinion in Cardiology, June 17, 2013 Clinical Article
14 The role of clopidogrel in the management of ischemic heart disease Current Opinion in Cardiology, June 17, 2013 Review Article Clinical Article
15 Long-term safety and efficacy of dual therapy with oral anticoagulation and clopidogrel in patients with atrial fibrillation treated with drug-eluting stents Clinical Research in Cardiology, June 17, 2013 Clinical Article
16 Impact of early statin therapy in patients with ischemic stroke or transient ischemic attack Acta Neurologica Scandinavica, June 17, 2013 Clinical Article
17 Should (beta)-blockers still be routine after myocardial infarction? Current Opinion in Cardiology, June 14, 2013 Clinical Article
18 Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures the PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity JACC - Journal of the American College of Cardiology, June 14, 2013 Clinical Article
19 Impact of medication non-adherence on survival after pediatric heart transplantation in the USA The Journal of Heart and Lung Transplantation, June 14, 2013 Clinical Article
20 Improved perioperative blood pressure control leads to reduced hospital costs Expert Opinion on Pharmacotherapy, June 13, 2013 Clinical Article
1 Antihypertensive Response to Combination of Olmesartan and Amlodipine Does Not Depend on Method and Time of Drug Administration High Blood Pressure & Cardiovascular Prevention, May 13, 2013
2 Statins and lipid metabolism Current Opinion in Lipidology, May 24, 2013 Review Article
3 Reversal of Oral Anticoagulation Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 30, 2013
4 Resistant hypertension: a practical clinical approach Journal of Human Hypertension, May 10, 2013
5 Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation Stroke, May 29, 2013
6 HDL Cholesterol: All Hope Is Not Lost After the Torcetrapib Setback- Emerging Therapeutic Strategies on the Horizon American Journal of Therapeutics, April 4, 2013
7 New Oral Anticoagulants in Non-Valvular Atrial Fibrillation High Blood Pressure & Cardiovascular Prevention, May 13, 2013
8 Ticagrelor: positive, negative and misunderstood properties as a new antiplatelet agent Clinical and Experimental Pharmacology and Physiology, April 23, 2013
9 Ouabain-The Key to Cardioprotection? American Journal of Therapeutics, April 24, 2013
10 Clinical utility of β-blockers for primary and secondary prevention of coronary artery disease Expert Review of Cardiovascular Therapy , April 1, 2013
11 Resistant Hypertension in the Elderly: Optimizing Outcomes While Avoiding Adverse Effects The Consultant Pharmacist, May 8, 2013
12 Differential Effects of Nebivolol Versus Metoprolol on Functional Sympatholysis in Hypertensive Humans Hypertension, May 16, 2013
13 Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials European Journal of Preventive Cardiology, March 7, 2013 Evidence Based Medicine Review Article
14 Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention Heart and Vessels, May 23, 2013
15 Blood pressure-lowering effect of simvastatin: a placebo-controlled randomized clinical trial with 24-h ambulatory blood pressure monitoring Journal of Human Hypertension, May 23, 2013
16 Efficacy and Effects on Lipid Metabolism of Combination Treatment With Losartan + Hydrochlorothiazide Versus Losartan + Amlodipine: A 48-Week Prospective, Multicenter, Randomized, Open-Label Trial Clinical Therapeutics, April 22, 2013
17 Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation Clinical and Experimental Pharmacology and Physiology, May 30, 2013 Review Article
18 Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events Vascular Health and Risk Management, May 20, 2013 Free full text
19 Optimal Blood Pressure Goals in Patients With Hypertension at High Risk for Cardiovascular Events American Journal of Therapeutics, April 23, 2013 Review Article
20 Effect of contrasted sodium diets on the pharmacokinetics and pharmacodynamic effects of renin-angiotensin system blockers Hypertension, May 29, 2013 Review Article
Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close